27788 Federal Register / Vol. 60, No. 101 / Thursday, May 25, 1995 / Notices

Information Systems, Massy CEDEX,

FRANCE; and International Computers

Limited, Bracknell, Berks, ENGLAND.

New Allied Sponsors of OSF, i.e., a

group of affiliated members which share

a single vote, are NEC Corporation,

Tokyo, JAPAN; Siemens Nixdorf

Informationssysteme AG, Munchen,

GERMANY; Silicon Graphics Computer

Systems, Mountain View, CA; Sony

Corporation, Tokyo, JAPAN; and

Transarc Corporation, Pittsburgh, PA.

The previous notification filed on

May 11, 1994 is hereby corrected to

show a change in address as follows:

Persetel (Pty) Ltd., Sandton,

Johannesburg, SOUTH AFRICA; USAF

ESD, Hanscom AFB, MA; and

University of Bilkent, Ankara, TURKEY;

and to add Unilever PLC/NV, London,

ENGLAND as a member of OSF.

No other changes have been made in

either membership or planned activity

of the group research project.

Membership in this group research

project remains open, and OSF intends

to file additional written notifications

disclosing all changes in membership.

On May 11, 1994, OSF filed its

original notification pursuant to Section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to Section 6(b) of the

Act on August 31, 1994 (59 Fed. Reg.

45009).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 95–12873 Filed 5–24–95; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; SI Diamond Technology,

Inc.

Notice is hereby given, that on March

21, 1995, pursuant to the National

Cooperative Research and Production

Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the

Act’’), SI Diamond Technology, Inc., for

itself and on behalf of its members, has

filed written notifications

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specified

circumstances. Pursuant to Section 6(b)

of the Act, the identities of the parties

are: SI Diamond Technology, Inc.,

Houston, TX; and Supertex, Inc.,

Sunnyvale, CA. The purpose of this

joint venture is to develop and

demonstrate diamond diode field

emission display process technology

needed for production of a 10’’, full

color, VGA, flat panel display. The

activities of this Joint Venture project

will be partially funded by an award

from the Advanced Technology

Program, National Institute of Standards

and Technology, Department of

Commerce.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 95–12874 Filed 5–24–95; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1311.42 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on February 17, 1994,

Calbiochem-Novabiochem Corporation,

10394 Pacific Center Court, Attn:

Receiving Inspector, San Diego,

California 92121–4340, made

application to the Drug Enforcement

Administration to be registered as an

importer of the basic classes of

controlled substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ..... I

Mescaline (7381) ......................... I

Amphetamine (1100) ................... II

Phencyclidine (7471) ................... II

Phenylacetone (8501) .................. II

Cocaine (9041) ............................ II

The firm plans to import small

quantities of the listed controlled

substances to make reagents for

distribution to the biomedical research

commodity.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of these basic classes of

controlled substances may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.54 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than June 26,

1995.

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1311.42 (b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–

43746 (September 23, 1975), all

applicants for registration to import

basic classes of any controlled

substances in Schedule I or II are and

will continue to be required to

demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1311.42 (a), (b), (c), (d), (e), and (f)

are satisfied.

Dated May 18, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–12782 Filed 5–24–95; 8:45 am]

BILLING CODE 4410–09–M

Importer of Controlled Substances;

Notice of Registration

By Notice dated April 25, 1994, and

published in the Federal Register on

May 4, 1994, (59 FR 23081), Cambridge

Isotope Lab, 50 Frontage Road, Andover,

Massachusetts 01810, made application

to the Drug Enforcement Administration

(DEA) to be registered as an importer of

the basic classes of controlled

substances listed below:

Drug Schedule

Dimethyltryptamine (7435) ........... I

Amphetamine (1100) ................... II

Methamphetamine (1105) ............ II

Phencyclidine (7471) ................... II

Cocaine (9041) ............................ II

Codeine (9050) ............................ II

Benzoylecgonine (9180) .............. II

Methadone (9250) ........................ II

Morphine (9300) ........................... II

Fentanyl (9801) ............................ II

No comments or objections have been

received. Therefore, pursuant to Section

1008(a) of the Controlled Substances

Import and Export Act and in

accordance with Title 21, Code of
Federal Register / Vol. 60, No. 101 / Thursday, May 25, 1995 / Notices 27789

Federal Regulations, Section 1311.42,

the above firm is granted registration as

an importer of the basic classes of

controlled substances listed above.

Dated: May 18, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–12779 Filed 5–24–95; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated October 20, 1994, and

published in the Federal Register on

October 28, 1994, (59 FR 54219),

Hoffman-LaRoche, Inc., 340 Kingsland

Street, Nutley, New Jersey 07110, made

application to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of Levorphanol

(9220), a basic class of controlled

substance listed in Schedule II.

No comments or objections have been

received. Therefore, pursuant to Section

303 of the Comprehensive Drug Abuse

Prevention and Control Act of 1970 and

Title 21, Code of Federal Regulations,

Section 1301.54(e), the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic class of controlled substance

listed above is granted.

Dated: May 17, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–12780 Filed 5–24–95; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Notice of Correction

In the Federal Register (FR Doc. 95–

8920) Vol. 60, No. 70 at page 18618,

dated April 12, 1995, the listing of

controlled substances should have

included Oxycodone (9143),

Hydromorphone (9150), Diphenoxylate

(9170) and Noroxymorphone (9668) for

Mallinckrodt Chemical, Inc.,

Mallinckrodt & Second Streets, St.

Louis, Missouri 63147.

Dated: May 17, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–12778 Filed 5–24–95; 8:45 am]

BILLING CODE 4410–09–M

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1311.42 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on January 18, 1995, North

Pacific Trading Company, 1505 SE

Gideon Street, Portland, Oregon 97202,

made application to the Drug

Enforcement Administration to be

registered as an importer of Marihuana

(7360) a basic class of controlled

substance in Schedule I.

This application is exclusively for the

importation of marithuana seed which

will be rendered non-viable and used as

bird seed.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of these basic classes of

controlled substances may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.54 in

such form as prescribed by 21 CFR

1305.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justices,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than June 26,

1995.

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1311.42(b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43747–46

(September 23, 1975), all applicants for

registration to import basic classes of

any controlled substances in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1311. 42 (a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: May 18, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–12783 Filed 5–24–95; 8:45 am]

BILLING CODE 4410–09–M

Importer of Controlled Substances;

Application Withdrawal for Nycomed

Incorporated

By letter dated April 17, 1995,

Nycomed Inc., 33 Riverside Avenue,

Rensselaer, New York 12144, withdrew

their request to be registered as an

importer of Meperidine (9230).

Therefore, the Notice dated February

14, 1995, in Federal Register (FR Doc.

95–3627), Vol. 60, No. 30 at page 8414

is hereby withdrawn.

Dated: May 17, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–12781 Filed 5–24–95; 8:45 am]

BILLING CODE 4410–09–M

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1311.42 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on March 22, 1995, Research

Biochemicals, Limited Partnership, One

Strathmore Road, Natick, Massachusetts

01760, made application to the Drug

Enforcement Administration to be

registered as an importer of the basic

classes of controlled substances listed

below;

Drug Schedule

Methaqualone (2565) ................... I

Ibogaine (7260) ............................ I

Tetrahydrocannabinois (7370) ..... I

Bufotenie (7433) .......................... I

Dimethyltryptamine (7435) ........... I

Etorphine (except HC1) (9056) .... I

Methylphenidate (1724) ............... II

Etorphine Hydrochloride (9059) ... II

Diphenoxylate (9170) ................... II